Working in the area of drug discovery against antibiotic-resistant organisms.

Summary

MetaLinear is working in the area of drug discovery against antibiotic-resistant organisms. The Company aims to develop libraries of engineered proteins. The end goal is the identification and production of proteins which effectively inhibit cell growth in bacteria that are currently resistant to antibiotic treatment

Product

Life Sciences SEIS

Sector

Drug discovery

Status

Closed

HMRC

Advanced Assurance